1. A Phase II Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Lenalidomide in Lumbar Radicular Pain with a Long-Term Open-Label Extension Phase. Issue 3 (19th August 2016) Authors: Manning, Donald C.; Gimbel, Joseph; Wertz, Robert; Rauck, Richard; Cooper, Alyse; Zeldis, Jerome B.; Levinsky, Dale M. Journal: Pain medicine Issue: Volume 18:Issue 3(2017) Page Start: 477 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Assessment of potentially abuse-related events in two phase 3 studies of NKTR-181, a novel opioid analgesic, using the MADDERS® system (Misuse, Abuse, and Diversion Drug Event Reporting System). (2nd September 2019) Authors: Lanier, Ryan K.; Henningfield, Jack E.; Gudin, Jeffrey; Rauck, Richard; Elder, Harrison; Erpelding, Nathalie; Treister, Roi; Gimbel, Joseph; Tagliaferri, Mary; Doberstein, Stephen K.; Di Fonzo, Carlo J.; Lu, Lin; Siddhanti, Suresh; Katz, Nathaniel P. Journal: Current medical research and opinion Issue: Volume 35:Number 9(2019) Page Start: 1513 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and tolerability of buccal buprenorphine in opioid-experienced patients with moderate to severe chronic low back pain: results of a phase 3, enriched enrollment, randomized withdrawal study. Issue 11 (November 2016) Authors: Gimbel, Joseph; Spierings, Egilius L.H.; Katz, Nathaniel; Xiang, Qinfang; Tzanis, Evan; Finn, Andrew Journal: Pain Issue: Volume 157:Issue 11(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Long-term Safety and Tolerability of NKTR-181 in Patients with Moderate to Severe Chronic Low Back Pain or Chronic Noncancer Pain: A Phase 3 Multicenter, Open-Label, 52-Week Study (SUMMIT-08 LTS). Issue 7 (30th July 2019) Authors: Gudin, Jeffrey; Rauck, Richard; Argoff, Charles; Agaiby, Eva; Gimbel, Joseph; Katz, Nathaniel; Doberstein, Stephen K; Tagliaferri, Mary; Tagliaferri, Margit; Potts, Jeffrey; Wild, James; Lu, Lin; Siddhanti, Suresh; Hale, Martin; Markman, John Journal: Pain medicine Issue: Volume 21:Issue 7(2020) Page Start: 1347 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Measuring Opioid Withdrawal in a Phase 3 Study of a New Analgesic, NKTR-181 (Oxycodegol), in Patients with Moderate to Severe Chronic Low Back Pain. Issue 8 (9th March 2020) Authors: Henningfield, Jack E; Gudin, Jeffrey; Rauck, Richard; Gimbel, Joseph; Tagliaferri, Mary; Doberstein, Stephen K; Di Fonzo, Carlo; Lu, Lin; Katz, Nathaniel; Siddhanti, Suresh; Schnoll, Sidney Journal: Pain medicine Issue: Volume 21:Issue 8(2020) Page Start: 1553 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. SUMMIT-07: a randomized trial of NKTR-181, a new molecular entity, full mu-opioid receptor agonist for chronic low-back pain. Issue 6 (June 2019) Authors: Markman, John; Gudin, Jeffrey; Rauck, Richard; Argoff, Charles; Rowbotham, Michael; Agaiby, Eva; Gimbel, Joseph; Katz, Nathaniel; Doberstein, Stephen K.; Tagliaferri, Mary; Lu, Lin; Siddhanti, Suresh; Hale, Martin Journal: Pain Issue: Volume 160:Issue 6(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗